Charles River Net Working Capital Over Time
| CRL Stock | USD 199.59 1.84 0.93% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Charles River Performance and Charles River Correlation. Charles |
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Charles River. If investors know Charles will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Charles River listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.21) | Earnings Share 8 | Revenue Per Share 78.97 | Quarterly Revenue Growth (0.02) | Return On Assets 0.0487 |
The market value of Charles River Labora is measured differently than its book value, which is the value of Charles that is recorded on the company's balance sheet. Investors also form their own opinion of Charles River's value that differs from its market value or its book value, called intrinsic value, which is Charles River's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Charles River's market value can be influenced by many factors that don't directly affect Charles River's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Charles River's value and its price as these two are different measures arrived at by different means. Investors typically determine if Charles River is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Charles River's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Working Capital Analysis
Compare Charles River Labora and related stocks such as ICON PLC, Mettler Toledo Inter, and Syneos Health Net Working Capital Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICLR | 535 M | 535 M | 535 M | 535 M | 535 M | 535 M | 535 M | 535 M | 719.6 M | 493.7 M | 979 M | 462.3 M | 538.5 M | 585.9 M | 493 M |
| MTD | 317.1 M | 317.1 M | 317.1 M | 317.1 M | 317.1 M | 317.1 M | 317.1 M | 317.1 M | 311.4 M | 355.1 M | 216.6 M | 122.8 M | 227.4 M | 49.1 M | 46.7 M |
| LH | 636.5 M | 636.5 M | 636.5 M | 636.5 M | 636.5 M | 636.5 M | 636.5 M | 636.5 M | 956.5 M | 325.4 M | 2 B | 2.5 B | 1.5 B | 540.2 M | 513.2 M |
| WAT | 3.7 B | 3.7 B | 3.7 B | 3.7 B | 3.7 B | 3.7 B | 3.7 B | 3.7 B | 2.2 B | 721.2 M | 596 M | 948.4 M | 978.2 M | 963.3 M | 1.2 B |
| IDXX | (32.6 M) | (32.6 M) | (32.6 M) | (32.6 M) | (32.6 M) | (32.6 M) | (32.6 M) | (32.6 M) | (116.3 M) | (45.7 M) | 480 M | 192.1 M | (134.3 M) | 543.7 M | 570.9 M |
| IQV | 546 M | 546 M | 546 M | 546 M | 546 M | 546 M | 546 M | 546 M | 340 M | 181 M | 532 M | (478 M) | (597 M) | (895 M) | (850.2 M) |
| RVTY | 605.7 M | 605.7 M | 605.7 M | 605.7 M | 605.7 M | 605.7 M | 605.7 M | 605.7 M | 605.7 M | 605.7 M | 586.7 M | 1.2 B | 1.7 B | 1.6 B | 1.3 B |
| CDNA | (16.1 M) | (16.1 M) | (16.1 M) | (16.1 M) | (16.1 M) | (16.1 M) | (16.1 M) | (16.1 M) | 61.6 M | 37.1 M | 203.9 M | 356.1 M | 311.9 M | 235.6 M | 187 M |
| GH | 223.3 M | 223.3 M | 223.3 M | 223.3 M | 223.3 M | 223.3 M | 223.3 M | 223.3 M | 422 M | 524.6 M | 1.8 B | 919.4 M | 998.4 M | 1.1 B | 950.8 M |
| ILMN | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.7 B | 3.8 B | 3.2 B | 1.6 B | 788 M | 1 B | 1.8 B |
| A | 2.9 B | 2.9 B | 2.9 B | 2.9 B | 2.9 B | 2.9 B | 2.9 B | 2.7 B | 1.1 B | 1.9 B | 2.1 B | 1.9 B | 2.6 B | 2.3 B | 1.7 B |
| MEDP | (62.7 M) | (62.7 M) | (62.7 M) | (62.7 M) | (62.7 M) | (62.7 M) | (62.7 M) | (62.7 M) | (78.9 M) | (26 M) | 33.5 M | 133.7 M | (469.5 M) | (331.3 M) | (314.7 M) |
Charles River Labora and related stocks such as ICON PLC, Mettler Toledo Inter, and Syneos Health Net Working Capital description
My Equities
My Current Equities and Potential Positions
| Charles River Laboratories | CRL |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Massachusetts; U.S.A |
| Exchange | New York Stock Exchange |
USD 199.59
Check out Charles River Performance and Charles River Correlation. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Charles River technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.